KIF3B has been shown to be over-expressed in multiple human cancers, such as gastric cancer, oral squamous cell carcinoma, pancreatic cancer, prostate cancer, seminoma, hepatocellular carcinoma, and acute lymphoblastic leukemia (34–40). Here, KIF3B is linked to cancer.